Nymox Pharmaceutical Corp (NASDAQ:NYMX)

4.19
Delayed Data
As of Apr 20
 +0.01 / +0.24%
Today’s Change
3.00
Today|||52-Week Range
5.10
+26.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues2.9M2.8M283.6K224.0K
 
 
 
 
 
Cost of Goods Sold173.7K160.3K173.0K149.0K
 
 
 
 
 
Depreciation And Amortization6.6K6.0K3.4K1.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.8M2.6M107.2K74.0K
 
 
 
 
 
General Expenses7.8M20.3M13.0M13.3M
 
 
 
 
 
Research And Development4.8M8.6M6.8M7.9M
 
 
 
 
 
Total Operating Expenses7.9M20.4M13.2M13.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.0M-17.7M-12.9M-13.2M
 
 
 
 
 
Extraordinary Credit189.6K0.000.000.00
 
 
Interest Expense On Debt86.8K187.8K233.8K204.0K
 
 
 
 
 
Other Expenses-24.6K-35.8K-10.1K-1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.9M-17.9M-13.1M-13.4M
 
 
 
 
 
Income Taxes-316.8K0.000.000.00
 
 
Net Income-4.6M-17.9M-13.1M-13.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.3M37.4M46.2M52.6M
 
 
 
 
 
Shares To Calculate EPS Diluted35.3M37.4M46.2M52.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.13-$0.48-$0.28-$0.26
 
 
 
 
 
EPS Diluted-$0.13-$0.48-$0.28-$0.26